Reverse remodeling in heart failure - Fact or fiction?

European Heart Journal, Supplement

Volumn 6, Issue D, 2004, Pages

  Pieske, Burkert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Heart failure; Reverse remodeling

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANEURYSM SURGERY; CELL DEATH; CELL LEVEL; DISEASE COURSE; ENDURANCE; EXERCISE; GENE TRANSFER; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART PACING; HEART RESYNCHRONIZATION THERAPY; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HEART VENTRICLE VOLUME; HUMAN; MITRAL VALVE REPLACEMENT; MORTALITY; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; REVERSE HEART REMODELING; REVIEW; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 3342991843     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehjsup.2004.05.019     Document Type: Review

References (100)

1. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronisation in chronic heart failure. N. Engl. J. Med. 346:2002;1845-1853
2. Alfieri O., Maisano F., Schreuder J.J. Surgical methods to reverse left ventricular remodeling in congestive heart failure. Am. J. Cardiol. 91(Suppl.):2003;81F-87F
3. Athanasuleas CL, Stanley Jr AW, Buckberg GD, Dor V, Di Donato M, Blackstone EH and the RESTORE group. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. J Am Coll Cardiol 2001;37:1199-1209
4. Auricchio A., Stellbrink C., Block M., et al. Effect of pacing chamber and atriventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation. 99:1999;2993-3001
5. Barbone A., Holmes J.W., Heerdt P.M., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure. Circulation. 104:2001;670-675
6. Barbone A., Oz M.C., Burkhoff D., et al. Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry. Circulation. 104(Suppl. I):2001;I-229-I-232
7. Bartling B., Milting H., Schumann H., et al. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation. 100(Suppl. II):1999;II-212-II-223
8. Batista R.J.V., Santos J.L.V., Takeshita N., et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. Can. J. Surg. 11:1996;96-97
9. Bolling S.F., Deeb G.M., Brunsting L.A., et al. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J. Thorac. Cardiovasc. Surg. 109:1995;676-682
10. Bolling S.F., Smolens I.A., Pagani F.D. Surgical alternatives for heart failure. J. Heart Lung Transplant. 20:2001;729-733
11. Bozkurt B., Torre-Amione G., Warren M.S., et al. Results of the anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 103:2001;1044-1047
12. Castigliono A., quarti A., Schreuder J., et al. Surgical restoration of the left ventricle for postinfarction aneurysm. Ital. Heart J. 3:2002;370-374
13. Chen L., Chen C.X., Gan X.T., et al. Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE1-inhibition. Am. J. Physiol. 286:2004;H381-H387
14. Cintron G., Johnson G., Francis G., et al. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 87(Suppl. 6):1993;VI17-VI23
15. Cohn J.N., Ferrari R., Sharpe N. On behalf of an international forum on cardiac remodeling. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J. Am. Coll. Cardiol. 35:2000;569-582
16. Cooley D.A. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation. 105:2002;2808-2809
17. De Jonge N., van Wichen D.F., Schipper M., et al. Left ventricular assist device in end-stage heart failure: persistance of structural myocyte damage after unloading. J. Am. Coll. Cardiol. 39:2002;963-969
18. del Monte F., Williams E., Lebeche D., et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation. 104:2001;1424-1429
19. Dipla K., Mattiello J.A., Jeevanandam V., et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 97:1998;2316-2322
20. Dor V. The endoventricular circular patch plasty ("Dor procedure") in ischemic akinetic dilated ventricles. Heart Fail. Rev. 6:2001;187-193
21. Doughty R.N., Whalley G.A., Gamble G., et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J. Am. Col. Cardiol. 29:1997;1060-1066
22. Doughty R.N., Whalley G.A., Walsh H.A., et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo substudy. Circulation. 109:2004;201-206
23. Duncan A., Wait D., Gibson D., et al. Left ventricular remodeling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythmus: sub-study of the MUSTIC (Multisite Stimulation in Cardiomyopathies) trial. Eur. Heart J. 24:2003;430-441
24. Engelhardt S., Hein L., Keller U., et al. Inhibition of Na/H exchange prevents hypertrophy, fibrosis, and heart failure in β1-adrenergic receptor transgenic mice. Circ. Res. 90:2002;814-819
25. Ennis I.L., Escudero E.M., Console G.M., et al. Regression of isoproterenol-induced cardiac hypertrophy by Na/H-exchanger inhibition. Hypertension. 41:2003;1324-1329
26. Flesch M., Margulies K.B., Mochmann H.-.C., et al. Differential regulation of mitogen-activated protein-kinases in the failing human heart in response to mechanical unloading. Circulation. 104:2001;2273-2276
27. Florea V.G., Mareyev V.Y., Samko A.N., et al. Left ventricular remodeling: common process in patients with different primary myocardial disorders. Int. J. Card. Fail. 68:1999;281-287
28. Francis G.S., Tang W.H.W. β-Blockers and reverse remodeling: what are the implications? Am. Heart J. 145:2003;200-202
29. Giannuzzi P., Temporelli L., Corrà U., et al. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure. Circulation. 108:2003;554-559
30. Gilbert E.M., Abraham W.T., Olsen S., et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 94:1996;2817-2825
31. Gras D., Leclercq C., Tang A., et al. Cardiac resynchronisation therapy in advanced heart failure: the multicenter InSync clinical study. Eur. J. Heart Fail. 4:2002;311-320
32. Greenberg B., Quinones M.A., Koilpillai C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiographic substudy. Circulation. 91:1995;2573-2581
33. Groenning B.A., Nilsson J.C., Sondergaard L., et al. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J. Am. Coll. Cardiol. 36:2000;2072-2080
34. Hall S.A., Cigarroa C.G., Marcoux L., et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J. Am. Coll. Cardiol. 25:1995;1154-1161
35. Hamdan M., Zagrodzsky J.D., Joglar J., et al. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation. 102:2000;1027-1032
36. Harding J.D., Piacentino III V., Gaughan J.P., et al. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation. 104:2001;1241-1247
37. Hasenfuss G., Pieske B. Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. 34:2002;951-969
38. Helman D.N., Maybaum S.W., Morales L.S., et al. Recurrent remodelling after ventricular assistance: is long-term myocardial recovery attainable. An. Thorac. Surg. 2000;1255-1258
39. Heerdt P.M., Holmes J.W., Cai B., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 102:2000;2713-2719
40. Hetzer R., Müller J., Weng Y., et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann. Thorac. Surg. 68:1999;742-749
41. Hetzer R., Jurmann M.J., Potapv E., et al. Cardiac assist devices-present status. Herz. 27:2002;407-417
42. Hochmann J.S., Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 75:1987;299-306
43. Hon J.K., Yacoub M. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann. Thorac. Surg. 75(Suppl.):2003;S36-S41
44. Horie H., Takahashi M., Minai K., et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angiography. Circulation. 98:1998;2377-2382
45. James K.B., McCarthy P.M., Thomas J.D., et al. Effect of implantable left ventricular device on neuroendocrine activation in heart failure. Circulation. 92(Suppl.):1995;II-191-II-195
46. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med. 348:2003;1233-1241
47. Karmazyn M. Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res. Cardiol. 96:2001;325-328
48. Kass D.A., chen C.H., Curry C., et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 99:1999;1567-1573
49. Katz A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 323:1990;100-110
50. Kawaki K., Takaoka H., Kata K., et al. Prevalence, predictors, and prognosis of reversal remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 84:1999;671-676
51. Khattar R.S., Senior R., Soman P., et al. Regression of left ventricular remodeling in chronic heart failure: comparative and combined effects of captopril and carvedilol. Am. Heart J. 142:2001;704-713
52. Konertz W.F., Shapland J.E., Hotz H., et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation. 104:2001;I-270-I-275
53. Konstam M.A., Rousseau M.F., Kronenberg M.W., et al. Effects of the angiotensin converting enzyme inhibitor, enalapril, on the long term progression of left ventricular dysfunction in patients with heart failure. SOLVD investigators. Circulation. 86:1992;431-438
54. Konstam M.A., Kronenberg M.W., Rousseau M.F., et al. Effects of the angiotensin converting enzyme inhibitor, enalapril, on the long term progression of left ventricular dilatation in patients with left ventricular dysfunction. SOLVD investigators. Circulation. 88:1993;2277-2283
55. Kücüker S.A., Stetson S.J., Becker K.A., et al. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. J. Heart Lung Transplant. 23:2004;28-35
56. Lechat P., Packer M., Chalon S., et al. Clinical effects of beta-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled trials. Circulation. 98:1998;1184-1191
57. Lee S.H., Doliba N., Osbakken M., et al. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. J. Thorac. Cardiovasc. Surg. 116:1998;344-349
58. Lenfant C. Clinical research to clinical practice-lost in translation? N. Engl. J. Med. 349:2003;868-874
59. Levin H.R., Oz M.C., Chen J.M., et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 91:1995;2717-2720
60. Levine T.B., Levine A.B., Bolenbaugh J., et al. Impact of left ventricular size on pharmacological remodelling in heart failure. Clin. Cardiol. 23:2000;355-358
61. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347:2002;1397-1402
62. Li Y.Y., Feng Y., McTiernan C.F., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 104:2001;1147-1152
63. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation In Cardiomyopathy (MUSTIC) Study. J. Am. Coll. Cardiol. 40:2002;111-118
64. Lowes B.D., Gilbert E.M., Abraham W.T., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N. Engl. J. Med. 346:2002;1357-1365
65. Mancini D.M., Beniaminowitz A., Levin H., et al. Low incidence of myocardial recovery in patients with left ventricular assist devices. Circulation. 98:1998;2383-2389
66. Mansfield D.R., Gollogly N.C., Kaye D.M., et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med. 169:2004;361-366
67. Marber M.S., Brown D.L., Kloner R.A. The Open Artery Hypothesis: to open or not, that is the question. Eur. Heart J. 17:1996;505-509
68. McCarthy P., Satoshi Nakatani S., Vargo R., et al. Structural and left ventricular histological changes after implantable LVAD insertion. An. Thorac. Surg. 59:1995;609-613
69. Metra M., Nodari S., Parrinello G., et al. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am. Heart J. 145:2003;292-299
70. Metzger M., Higuchi M.L., Moreira L.F., et al. Relevance of apoptosis and cell proliferation for survival of patients with dilated cardiomyopathy undergoing partial left ventriculectomy. Eur. J. Clin. Invest. 32:2002;394-399
71. Müller J., Wallukat G., Weng Y., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 96:1997;542-549
72. Noirhomme P., Jacquet L., Underwood M., et al. The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure. Eur. J. Cardio-thoracic Surg. 16:1999;63-67
73. Ogletree-Hughes M., Stull L.B., Sweet W.E., et al. Mechanical unloading restores β-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation. 104:2001;881-886
74. Olsen S.L., Gilbert E.M., Renlund D.G., et al. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J. Am. Col. Cardiol. 25:1995;1225-1231
75. Penicka M., Bartunek J., de Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronisation therapy is predicted by tissue doppler imaging echocardiography. Circulation. 109:2004;978-983
76. Pfeffer M.A., Lamers G.A., Vaughan D.E., et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N. Engl. J. Med. 319:1988;80-86
77. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction: experimental observation and clinical implications. Circulation. 81:1990;1161-1172
78. Pieske B., Maier L.S., Bers D.M., et al. Ca handling and SR Ca content in isolated failing and nonfailing human myocardium. Circ. Res. 85:1999;38-46
79. Pitzalis M.V., Iacoviello M., Romito R., et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J. Am. Coll. Cardiol. 40:2002;1615-1622
80. Quinones M.A., Greenberg B.H., Kopelen H.A., et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. J. Am. Coll. Cardiol. 35:2000;1237-1244
81. Reinlib L., Abraham W. Recovery from heart failure with circulatory assist: a working group of the National Heart, Lung, and Blood Institute. J. Card. Fail. 9:2003;459-463
82. Reiken S., Wehrens X., Vest J., et al. β-Blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation. 107:2003;2459-2466
83. Sharpe N., Smith H., Murphey J., et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition. Lancet. 337:1991;872-876
84. Sin D.D., Logan A.G., Fitzgerald F.S., et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 102:2000;61-66
85. Small K.M., Wagoner L.E., Levin A.M., et al. Synergistic polymorphism of β1 and alpha2C-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 347:2002;1135-1142
86. Stellbrink C., Breithardt O.A., Franke A., et al. Impact of cardiac resynchronisation therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J. Am. Coll. Cardiol. 38:2001;1957-1965
87. St. John Sutton M., Pfeffer M.A., Moye L., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Circulation. 96:1997;3294-3299
88. St. John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after myocardial infarction. Circulation. 89:1994;68-75
89. St. John Sutton M., Plappert T., Abraham T., et al. Effect of cardiac resynchronisation therapy on left ventricular size and function in chronic heart failure. Circulation. 107:2003;1985-1990
90. Tang W.H.W., Larson M.S., Prikazsky L., et al. Reversal remodeling following long-term carvedilol therapy is associated with improvement in survival: the Stanford carvedilol echocardiographic registry [Abstract]. J. Am. Coll. Cardiol. 39(2 Suppl. A):2002;141A
91. Terracciano C.M.N., Harding S.E., Adamson D., et al. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur. Heart J. 24:2003;1329-1339
92. Tevaerai H.T., Eckart A.D., Walton G.B., et al. Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiated the functional recovery of unloaded failing hearts. Circulation. 106:2002;124-129
93. Torre-Amione G., Stetson S.J., Youker K.A., et al. Decreased expression of tumor necrosis factor-. α in failing human myocardium after mechanical circulatory support Circulation. 100:1999;1189-1193
94. Toussaint J.F., Lavergne T., Ollitraut J., et al. Biventricular pacing in severe heart failure patients reverses electromechanical dyssynchrony from apex to base. PACE. 23(Pt. II):2000;1731-1734
95. Ukkonen H., Beanlands R.S., Burwash I.G., et al. Effect of cardiac resynchronisation on myocardial efficiency and regional oxidative metabolism. Circulation. 107:2003;28-31
96. Vatta M., Stetson S.J., Perez-Verdia A., et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assist-device therapy. Lancet. 359:2002;936-941
97. Vatta M., Stetson S.J., Jimenez S., et al. Molecular normalisation of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J. Am. Coll. Cardiol. 43:2004;811-817
98. Wong M, Staszewsky L, Latini R, Barlera S, Volpi A, Chiang Y-T, Benza RL, Gottlieb SO, Kleemann TD, Rosconi F, Vandervoort PM, Cohn J for the Val-HeFT investigators. Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. J Am Coll Cardiol 2002;40:970-75
99. Yu C.M., Chau E., Sanderson J.E., et al. Tissue doppler echocardiographic evidence for reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 105:2002;438-445
100. Zafeiridis A., Jeevanandam V., Houser S.R., et al. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 98:1998;656-662